Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell

Eur Arch Otorhinolaryngol. 2023 Feb;280(2):757-763. doi: 10.1007/s00405-022-07570-w. Epub 2022 Jul 29.

Abstract

Purpose: The management of post-COVID-19 persistent olfactory dysfunction (OD) is uncertain. Currently, olfactory training is the only evidence-based therapy for post-viral OD. In this study, we evaluated the effectiveness of classical olfactory training (COT) in the treatment of post-COVID-19 persistent OD.

Materials and methods: Patients with persistent OD after COVID-19 were assessed using the Sniffin' Sticks test. Fifty-one patients were then divided into two groups based on personal preference: the COT group (n = 31) included subjects who performed COT over 12 weeks, and the control group (n = 20) included subjects who did not receive any treatment. After the exclusion of eight patients, the olfactory performances of 43 patients were re-evaluated and compared to the baseline values.

Results: A significantly higher proportion of patients in the COT group improved their olfactory scores above the clinically important difference compared to the control group (40% versus 6%) (p = 0.014). The subjective smell improvement by COT was independent of age, gender, OD duration, presence of parosmia, or the initial olfactory score (all p > 0.05).

Conclusion: Twelve weeks of COT appears to increase the olfactory sensitivity in patients with persistent OD following COVID-19.

Keywords: Anosmia; COVID-19; Hyposmia; Loss of smell; Olfactory dysfunction; Olfactory training.

MeSH terms

  • Anosmia / etiology
  • Anosmia / therapy
  • COVID-19* / complications
  • Humans
  • Olfaction Disorders* / etiology
  • Olfaction Disorders* / therapy
  • Olfactory Training
  • Smell

Grants and funding